Having a great time at my first #WCLC26@IASLC in Seoul! Learning a lot from talks on new ADCs, multidisciplinary survivorship care, and advances in lung cancer screening and early detection.
Thank you to @FrankWeinbergMD@UICancerCenter for their support in our project on real-world outcomes with clinical trial enrollment for patients with NSCLC at @UIHealth!
Landmark, practice changing study at #WCLC26. The phase III MAVERICK study shows no improvement in OS with PCI for SCLC, across limited and extensive stages, with worse cognitive failure free survival and increased toxicity in PCI arm.
The end of the PCI era.